Calcific aortic valve stenosis

There are 28 papers on calcific aortic valve stenosis in aging research: 8 observational studies in people, 20 reviews. The newest story, Oct 26, 2026: “Abdominal artery calcium is linked to heart valve narrowing”.

Disease

28 papers study it7 more mention it23 findings

3 new papers in 30 daysSee all 35 papers on calcific aortic valve stenosis

At a glance

Human genetic analyses link metabolic syndrome, larger waist circumference and higher triglycerides with greater calcific aortic valve stenosis risk. A cohort of women links moderate-to-severe abdominal aortic calcification with higher stenosis risk, while reviews describe associations with lipoprotein(a), its genetic determinants and oxidized phospholipids.

23 findings in 16 papers from 2016 to 2026, 6 of them since August 2026

“The presence of moderate-or-severe AAC was associated with a 2.5-to-3-fold increase in the relative hazard of incident CAS in the adjusted analysis”
The association between abdominal aortic calcification on lateral spine images captured during bone mineral density testing and incident aortic valve stenosisESC Congress 2026 abstract2026doi:10.1093/eurheartj/ehag785.3796
  • Humans8

Upstream

2

Remnant cholesterol

mediatesin humans1

1 study
  1. Remnant cholesterol is linked with calcific aortic valve stenosis in humans.

    “Small very-low-density lipoprotein particles, apolipoprotein B, and remnant cholesterol are key mediators linking MetS, WC, TG and CAVS.”

    Humanstwo-step Mendelian randomization; mediating metabolic syndrome, waist circumference and triglyceride effects, together with small VLDL particles and apolipoprotein B

    Causal inference and mediating pathways of metabolic syndrome on calcific aortic valve stenosis: linkage disequilibrium score regression and two-sample, two-step mendelian randomization study

    Journal of cardiothoracic surgery

More on Remnant cholesterol

Serum calcium

no changein silico1

1 study
  1. Serum calcium showed no clear effect on calcific aortic valve stenosis in silico (all P > 0.05/5 = 0.01).

    “Serum calcium, phosphate, 25OH-VitD, and PTH failed to show causal effects on CAVS at Bonferroni-corrected significance”

    In silico

    Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis

    NPJ cardiovascular health

More on Serum calcium

Associations

11

Lipoprotein

upin humans7upin reviews2

9 studies
  1. Lipoprotein raises the risk of calcific aortic valve stenosis in humans.

    “and it is also causally implicated in calcific aortic valve stenosis.”

    Review

    Lipoprotein(a) in the statin era: from risk marker to therapeutic target

    Frontiers in pharmacology

  2. Lipoprotein raises the risk of calcific aortic valve stenosis in humans (elevated concentrations (particularly ≥ 125 nmol/L)).

    “individuals with elevated concentrations (particularly ≥ 125 nmol/L) face substantial incremental ASCVD and CAVS risk.”

    Reviewelevated concentrations (particularly ≥ 125 nmol/L)

    Lipoprotein(a) in Japan: An Expert Consensus Statement

    Journal of atherosclerosis and thrombosis

  3. Lipoprotein raises the risk of calcific aortic valve stenosis.

    “causal, independent risk factor for atherosclerotic cardiovascular disease and calcific aortic valve stenosis”

    Review

    Lipoprotein(a) measurement: challenges and opportunities

    Clinical chemistry and laboratory medicine

  4. Lipoprotein raises the risk of calcific aortic valve stenosis in humans (genetically determined).

    “independent and causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve stenosis (CAVS)”

    Reviewgenetically determined

    Lipoprotein(a) in Personalized Cardiovascular Prevention: Risk Stratification, Coronary Artery Calcium, and Emerging Lp(a)-Lowering Therapies

    Journal of clinical medicine

  5. Lipoprotein raises the risk of calcific aortic valve stenosis in humans (elevated Lp(a)).

    “Lipoprotein(a) [Lp(a)] is a causal, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve stenosis (CAVS).”

    Reviewelevated Lp(a)

    Lipoprotein(a) and Cardiovascular Disease: From Genetic Risk Factor to Therapeutic Target

    Cells

  6. Lipoprotein raises the risk of calcific aortic valve stenosis in humans (genetically determined).

    “independent risk factor for atherosclerotic cardiovascular disease, including acute coronary syndrome, peripheral arterial disease, and stroke, as well as calcific aortic stenosis”

    Reviewgenetically determined

    Clinical Care for Patients With Elevated Lipoprotein(a) Level in Canada: A Practical Framework for Screening, Risk Assessment, and Management

    The Canadian journal of cardiology

  7. Lipoprotein raises the risk of calcific aortic valve stenosis in humans (genetically determined).

    “Lipoprotein(a) [Lp(a)] is a genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve stenosis (CAVS)”

    Reviewgenetically determined

    A Position Paper on Lipoprotein(a) From the Lipoprotein(a) Task Force of the Korean Society of Lipid and Atherosclerosis: Current Evidence, Clinical Applications, and Future Directions

    Korean circulation journal

  8. Lipoprotein is associated with calcific aortic valve stenosis.

    “Lp(a) is strongly associated with calcific aortic valve stenosis (CAVS), coronary artery disease (CAD), peripheral arterial disease (PAD)”

    Review

    Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective

    Atherosclerosis

  9. Lipoprotein predicts calcific aortic valve stenosis in humans.

    “Elevated plasma lipoprotein(a) and oxidized phospholipids predict progression of pre-existing aortic stenosis and need for aortic valve replacement.”

    Review

    Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis

    Current opinion in cardiology

More on Lipoprotein

Metabolic syndrome

upin humans1OR 1.82

1 study
  1. Metabolic syndrome is associated with calcific aortic valve stenosis in humans (linkage disequilibrium score regression, genetic correlation) (rg = 0.264, p = 4.61 × 10–26).

    “LDSC analysis identified MetS and CAVS (rg = 0.264, p = 4.61 × 10–26)”

    Humanslinkage disequilibrium score regression, genetic correlation

    Causal inference and mediating pathways of metabolic syndrome on calcific aortic valve stenosis: linkage disequilibrium score regression and two-sample, two-step mendelian randomization study

    Journal of cardiothoracic surgery

  2. Metabolic syndrome is linked with a higher risk of calcific aortic valve stenosis in humans (two-sample Mendelian randomization using GWAS summary statistics) (OR = 1.82, 95%CI = 1.60–2.07).

    “In the two-sample MR study, Mets (p = 1.39 × 10–20, OR = 1.82, 95%CI = 1.60–2.07)”

    Humanstwo-sample Mendelian randomization using GWAS summary statistics

    Causal inference and mediating pathways of metabolic syndrome on calcific aortic valve stenosis: linkage disequilibrium score regression and two-sample, two-step mendelian randomization study

    Journal of cardiothoracic surgery

More on Metabolic syndrome

Abdominal aortic calcification

upin humans1HR 2.81

1 study
  1. Abdominal aortic calcification is associated with calcific aortic valve stenosis in humans (Moderate-or-severe AAC (AAC-24 ≥2) versus low AAC (AAC-24 of 0 or 1); adjusted analysis) (HR 2.81, 95% CI 1.27–6.20).

    “The presence of moderate-or-severe AAC was associated with a 2.5-to-3-fold increase in the relative hazard of incident CAS in the adjusted analysis”

    HumansModerate-or-severe AAC (AAC-24 ≥2) versus low AAC (AAC-24 of 0 or 1); adjusted analysisabdominal aorta14.5 yearsfemalesn = 1,046

    Abdominal artery calcium is linked to heart valve narrowing

    ESC Congress 2026 abstract

More on Abdominal aortic calcification

LPA

upin humans1

1 study
  1. LPA raises the risk of calcific aortic valve stenosis in humans (genetic and Mendelian randomization evidence).

    “Genetic and Mendelian randomization studies support a likely causal contribution of the LPA locus and lifelong exposure to apoB-containing lipoproteins to aortic valve calcification and incident CAVS.”

    Reviewgenetic and Mendelian randomization evidence

    Lipoprotein(a) and calcific aortic stenosis: from inherited risk marker to therapeutic target

    Frontiers in medicine

More on LPA

Hdl cholesterol

downin humans1OR 0.9

1 study
  1. Hdl cholesterol is linked with a lower risk of calcific aortic valve stenosis in humans (two-sample Mendelian randomization using GWAS summary statistics) (OR = 0.9, 95%CI = 0.82–0.99).

    “high-density lipoprotein (HDL-C, p = 0.002, OR = 0.9, 95%CI = 0.82–0.99)”

    Humanstwo-sample Mendelian randomization using GWAS summary statistics

    Causal inference and mediating pathways of metabolic syndrome on calcific aortic valve stenosis: linkage disequilibrium score regression and two-sample, two-step mendelian randomization study

    Journal of cardiothoracic surgery

More on Hdl cholesterol

Triglycerides

upin humans1OR 1.42

1 study
  1. Triglycerides are linked with a higher risk of calcific aortic valve stenosis in humans (two-sample Mendelian randomization using GWAS summary statistics) (OR = 1.42, 95%CI = 1.22–1.65).

    “triglycerides (TG, p = 2.24 × 10− 9, OR = 1.42, 95%CI = 1.22–1.65)”

    Humanstwo-sample Mendelian randomization using GWAS summary statistics

    Causal inference and mediating pathways of metabolic syndrome on calcific aortic valve stenosis: linkage disequilibrium score regression and two-sample, two-step mendelian randomization study

    Journal of cardiothoracic surgery

More on Triglycerides

Waist circumference

upin humans1OR 1.51

1 study
  1. Waist circumference is linked with a higher risk of calcific aortic valve stenosis in humans (two-sample Mendelian randomization using GWAS summary statistics) (OR = 1.51, 95%CI = 1.33–1.72).

    “waist circumference (WC, p = 5.50 × 10–10, OR = 1.51, 95%CI = 1.33–1.72)”

    Humanstwo-sample Mendelian randomization using GWAS summary statistics

    Causal inference and mediating pathways of metabolic syndrome on calcific aortic valve stenosis: linkage disequilibrium score regression and two-sample, two-step mendelian randomization study

    Journal of cardiothoracic surgery

More on Waist circumference

CAVS risk-prediction nomogram

upin humans1

1 study
  1. CAVS risk-prediction nomogram predicts calcific aortic valve stenosis in humans (AUC = 0.907 (95% CI 0.855–0.958)).

    “AUC = 0.907 (95% CI 0.855–0.958) for the validation set.”

    Humansn = 174

    Development and Internal Validation of a Risk-Prediction Nomogram for Calcific Aortic Valve Stenosis: A Single-Center Real-World Study

    Research SquarePreprint

More on CAVS risk-prediction nomogram

Cardiometabolic disorder

mixedin humans1

1 study
  1. Cardiometabolic disorder is associated with calcific aortic valve stenosis in humans (Genetic overlap and bidirectional two-sample Mendelian randomization analysis) (12 shared genes).

    “Our study indicates significant genetic overlap between cardiometabolic disorders and CAVS.”

    HumansGenetic overlap and bidirectional two-sample Mendelian randomization analysis

    Shared genetic links between cardiometabolic diseases and aortic valve calcification

    Indian journal of thoracic and cardiovascular surgery

More on Cardiometabolic disorder

FGF23

upin silico1

1 study
  1. FGF23 raises the risk of calcific aortic valve stenosis in silico.

    “genetic mimicry of serum FGF23 elevation was associated with increased CAVS risk”

    In silico

    Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis

    NPJ cardiovascular health

More on FGF23

All 11

Funding

1 grant since 2023

Japan Society for the Promotion of Science¥4.8M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    A human Mendelian randomization analysis links metabolic syndrome, triglycerides and waist circumference with higher calcific aortic valve stenosis risk, and HDL cholesterol with lower risk. A human study links abdominal aortic calcification with higher risk in women; reviews describe links with lipoprotein(a), oxidized phospholipids and LPA.

  2. Summary rewritten as its findings changed.

    As it read before

    Reviews link lipoprotein(a) with calcific aortic valve stenosis, including genetically determined risk. A human Mendelian randomization study links metabolic syndrome, triglycerides, and waist circumference with higher risk and HDL cholesterol with lower risk. In women, abdominal aortic calcification is associated with subsequent stenosis.

  3. Summary rewritten as its findings changed.

    As it read before

    Reviews link lipoprotein and LPA to calcific aortic valve stenosis. Human Mendelian randomization analyses link metabolic syndrome, triglycerides and waist circumference with higher risk and HDL cholesterol with lower risk; a cohort study in women links abdominal aortic calcification with higher risk. In silico analyses report increased risk with FGF23 but no clear effect of serum calcium.

  4. Summary rewritten as its findings changed.

    As it read before

    Human genetic analyses link metabolic syndrome, triglycerides and waist circumference with higher calcific aortic valve stenosis risk, and HDL cholesterol with lower risk. In women, abdominal aortic calcification is associated with higher risk. Reviews link lipoprotein and LPA with the disease, including through genetic and Mendelian randomization analyses.

  5. Summary rewritten as its findings changed.

    As it read before

    Reviews link elevated lipoprotein concentrations and LPA with calcific aortic valve stenosis in humans. A human cohort associates abdominal aortic calcification with subsequent stenosis in women. An in silico study links metabolic syndrome, triglycerides and waist circumference with higher stenosis risk, and HDL cholesterol with lower risk.

Latest

Dec 2025: 1Jan 2026: 2Feb 2026: 2Mar 2026: 4Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 7Sep 2026: 5Oct 2026: 5Nov 2026: 127 papers in 12 months
ESC Congress 2026 Abstract

Abdominal artery calcium is linked to heart valve narrowing

In older women, moderate or severe abdominal artery calcium was linked to a hazard ratio of 2.81 for heart valve narrowing compared with low calcium.In older women, moderate or severe abdominal artery calcium was linked to a hazard ratio of 2.81 for heart valve narrowing compared with low calcium.

Cohort · 1,046 peopleBiomarkers

See all 35 papers on calcific aortic valve stenosis